Bristol Myers Squibb CEO Chris Boerner sat down with CNBC’s Angelica Peebles at the American Society of Clinical Oncology’s annual meeting to discuss the company’s latest cancer drug data, its $15 billion deal with China’s Hengrui, and more.
Thursday, June 4
